Back to Health Journal
July 2026 8 min readWeight Loss

Tirzepatide vs Semaglutide for Weight Loss: Which Is Better?

JB

James Boyd

Founder, Apex Health & Fitness | Former NFL Player

Tirzepatide vs semaglutide weight loss comparison

Semaglutide and tirzepatide are the two most effective weight loss medications available today. They sound similar — both are once-weekly injectable GLP-1 medications that dramatically reduce appetite — but they are not the same drug, and understanding the difference matters when choosing a treatment.

This guide compares tirzepatide vs semaglutide for weight loss: how they work, how much weight you can expect to lose, side effects, pricing, and how to choose with your clinician.

The Short Answer

Tirzepatide generally produces more weight loss than semaglutide because it activates two hormone receptors instead of one. In clinical trials:

  • Semaglutide: ~15% average weight loss over 68 weeks
  • Tirzepatide: ~20–22% average weight loss over 72 weeks

Both are excellent options. The "better" choice depends on your goals, tolerance, budget, and medical history — which is why a clinician review is essential.

How Each Medication Works

Semaglutide (GLP-1 Agonist)

Semaglutide mimics a single gut hormone called GLP-1 (glucagon-like peptide-1). It reduces appetite, slows stomach emptying, and improves blood sugar control. It is the active ingredient in Ozempic and Wegovy, and is available compounded with B12. See our compounded semaglutide program.

Tirzepatide (Dual GLP-1 + GIP Agonist)

Tirzepatide mimics two gut hormones — GLP-1 and GIP (glucose-dependent insulinotropic polypeptide). This dual mechanism is the key reason it tends to produce greater weight loss. It is the active ingredient in Mounjaro and Zepbound, and is available compounded with B12 or glycine. See our compounded tirzepatide program.

Tirzepatide vs Semaglutide at a Glance

| Feature | Semaglutide | Tirzepatide | | --- | --- | --- | | Mechanism | GLP-1 agonist | Dual GLP-1 + GIP agonist | | Receptors activated | 1 | 2 | | Dosing | Weekly injection (or daily sublingual) | Weekly injection | | Avg. weight loss | ~15% over 68 weeks | ~20–22% over 72 weeks | | Compounded price | $239/mo | $339/mo | | Best for | Steady, well-tolerated loss | Higher average weight loss |

Weight Loss Compared

The headline difference is magnitude. Tirzepatide's dual action on both GLP-1 and GIP receptors produces a greater average reduction in body weight, and patients often reach higher percentage weight-loss milestones more quickly than on semaglutide.

That said, individual results vary widely. Factors that influence your personal outcome include:

  • Starting body weight and BMI
  • Dose reached during titration
  • Nutrition and activity level
  • Adherence to the weekly dosing schedule
  • Individual hormonal response

Semaglutide remains a highly effective option — 15% average weight loss is life-changing for many patients, and some prefer its slightly gentler side-effect profile.

Side Effects Compared

Both medications share a similar side-effect profile because they work through the same gut-hormone pathway. The most common effects are gastrointestinal:

  • Nausea (most common, especially during titration)
  • Diarrhea or constipation
  • Reduced appetite (the intended effect)
  • Mild fatigue
  • Occasional acid reflux

These effects are typically dose-dependent and most pronounced during the first few weeks of a new dose. This is why both medications use a gradual titration schedule — starting low and increasing over time to let your body adjust. Most side effects subside as your body adapts.

Tirzepatide's side effects can be slightly more pronounced given its stronger effect, but both are generally well-tolerated when titrated properly under clinician supervision.

Pricing Compared

Through telehealth compounding, both medications are dramatically cheaper than their branded counterparts (Wegovy and Zepbound can exceed $1,000/month). At ApexOneMd, all-inclusive monthly pricing is:

  • Compounded semaglutide with B12 (injection): $239/mo
  • Semaglutide sublingual ODT (no needles): $219/mo
  • Compounded tirzepatide with B12 (injection): $339/mo
  • Tirzepatide with glycine (injection): $339/mo

All prices include the medication, supplies, shipping, lab work, and provider visits — with no insurance required and the ability to cancel anytime.

Which Should You Choose?

There's no universally "right" answer — it depends on your situation. Here's how to think about it:

Choose semaglutide if you:

  • Want steady, well-tolerated weight loss
  • Prefer a lower monthly cost
  • Want a sublingual (needle-free) option
  • Are new to GLP-1 medications

Choose tirzepatide if you:

  • Want the highest average weight loss available
  • Have more weight to lose
  • Tried semaglutide and want stronger results
  • Are comfortable with the higher monthly cost

Many clinicians start patients on semaglutide and switch to tirzepatide if more weight loss is needed. Others go straight to tirzepatide for maximum results. Either way, the decision should be made with a clinician after reviewing your labs.

Getting Started

Both semaglutide and tirzepatide are available through ApexOneMd with board-certified clinicians in all 50 states. The process is the same for either: complete an intake, get labs, have a clinician review, and if approved, your medication ships from a state-licensed compounding pharmacy.

Ready to compare your options with a clinician? Start your intake, or explore the compounded semaglutide and compounded tirzepatide treatment pages for full details.

JB

James Boyd

Founder, Apex Health & Fitness | Former NFL Player

Combining evidence-based fitness programming with physician-guided telehealth solutions to help members perform at their best.

Ready to choose your GLP-1?

Board-certified clinicians in all 50 states. Semaglutide from $219/mo, tirzepatide from $339/mo — all-inclusive.